250
Views
3
CrossRef citations to date
0
Altmetric
In vitro and animal studies

In vitro activities of inulin fermentation products to HCT-116 cells enhanced by the cooperation between exogenous strains and adult faecal microbiota

, & ORCID Icon
Pages 814-823 | Received 13 Aug 2017, Accepted 14 Dec 2017, Published online: 10 Jan 2018

References

  • Apolinario AC, de Lima Damasceno BP, de Macedo Beltrao NE, Pessoa A, Converti A, da Silva JA. 2014. Inulin-type fructans: a review on different aspects of biochemical and pharmaceutical technology. Carbohyd Polym. 101:368–378.
  • Barker SB, Summerson WH. 1941. The colorimetric determination of lactic acid in biological material. J Biol Chem. 138:535–554.
  • Belenguer A, Duncan SH, Calder AG, Holtrop G, Louis P, Lobley GE, Flint HJ. 2006. Two routes of metabolic cross-feeding between Bifidobacterium adolescentis and butyrate- producing anaerobes from the human gut. Appl Environ Microbiol. 72:3593–3599.
  • Borowicki A, Michelmann A, Stein K, Scharlau D, Scheu K, Obst U, Glei M. 2011. Fermented wheat aleurone enriched with probiotic strains LGG and Bb12 modulates markers of tumor progression in human colon cells. Nutr Cancer. 63:151–160.
  • Bosscher D, Breynaert A, Pieters L, Hermans N. 2009. Food-based strategies to modulate the composition of the intestinal microbiota and their associated health effects. J Physiol Pharmacol. 60(Suppl):5–11.
  • Beyer-Sehlmeyer G, Glei M, Hartmann E, Hughes R, Persin C, Bohm V, Rowland I, Schubert R, Jahreis G, Pool-Zobel BL. 2003. Butyrate is only one of several growth inhibitors produced during gut flora-mediated fermentation of dietary fibre sources. Br J Nutr. 90:1057–1070.
  • Campos-Vega R, García-Gasca T, Guevara-Gonzalez R, Ramos-Gomez M, Oomah BD, Loarca-Piña G. 2012. Human gut flora-fermented nondigestible fraction from vooked bean (Phaseolus vulgaris L.) modifies protein expression associated with apoptosis, cell cycle arrest, and proliferation in human adenocarcinoma colon cancer cells. J Agric Food Chem. 60:12443–12450.
  • Corry JEL, Curtis GDW, Baird RM. 1995. Culture media for food microbiology. Amsterdam: Elsevier Science B.V.
  • Doherty JR, Cleveland JL. 2013. Targeting lactate metabolism for cancer therapeutics. J Clin Invest. 123:3685–3692.
  • Feng M, Zhong LX, Zhan ZY, Huang ZH, Xiong JP. 2016. Resveratrol treatment inhibits proliferation of and induces apoptosis in human colon cancer cells. Med Sci Monit. 22:1101–1108.
  • Geng Q, Zhao XH. 2015. Influences of exogenous probiotics and tea polyphenols on the production of three acids during the simulated colonic fermentation of maize resistant starch. J Food Sci Technol. 52:5874–5881.
  • Griffin IJ, Hicks PMD, Heaney RP, Abrams SA. 2003. Enriched chicory inulin increases calcium absorption mainly in girls with lower calcium absorption. Nutr Res. 23:901–909.
  • Hamer HM, Jonkers D, Venema K, Vanhoutvin S, Troost FJ, Brummer RJ. 2008. Review article: the role of butyrate on colonic function. Aliment Pharmacol Ther. 27:104–119.
  • Hatayama H, Washita J, Kuwajima A, Abe T. 2007. The short chain fatty acid, butyrate, stimulates MUC2 mucin production in the human colon cancer cell line, LS174T. Biochem Bioph Res Co. 356:599–603.
  • Hoentjen F, Welling GW, Harmsen HJ, Zhang X, Snart J, Tannock GW, Lien K, Churchill TA, Lupicki M, Dieleman LA. 2005. Reduction of colitis by prebiotics in HLA-B27 transgenic rats is associated with microflora changes and immunomodulation. Inflamm Bowel Dis. 11:977–985.
  • Hosokawa M, Kudo M, Maeda H, Kohno H, Tanaka T, Miyashita K. 2004. Fucoxanthin induces apoptosis and enhances the antiproliferative effect of the ppar gamma ligand, troglitazone, on colon cancer cells. BBA-Gen Subjects. 1675:113–119.
  • Ichim TE, Patel AN, Shafer KA. 2016. Experimental support for the effects of a probiotic/digestive enzyme supplement on serum cholesterol concentrations and the intestinal microbiome. J Transl Med. 14:e184.
  • Jonathan MC, van den Borne JJGC, van Wiechen P, da Silva CS, Schols HA, Gruppen H. 2012. In vitro fermentation of 12 dietary fibres by faecal inoculum from pigs and humans. Food Chem. 133:889–897.
  • Kaelin WG, Thompson CB. 2010. Q&A: cancer: clues from cell metabolism. Nature. 465:562–564.
  • Karimi R, Azizi MH, Ghasemlou M, Vaziri M. 2015. Application of inulin in cheese as prebiotic, fat replacer and texturizer: a review. Carbohydr Polym. 119:85–100.
  • Kautenburger T, Beyer-Sehlmeyer G, Festag G, Haag N, Kühler S, Küchler A, Weise A, Marian B, Peters WH, Liehr T, et al. 2005. The gut fermentation product butyrate, a chemopreventive agent, suppresses glutathione S-transferase theta (hGSTT1) and cell growth more in human colon adenoma (LT97) than tumor (HT29) cells. J Cancer Res Clin Oncol. 131:692–700.
  • Lebet V, Arrigoni E, Amadò R. 1998. Measurement of fermentation products and substrate disappearance during incubation of dietary fibre sources with human faecal flora. LWT – Food Sci Technol. 31:473–479.
  • Leonel AJ, Alvarez-Leite JI. 2012. Butyrate: implications for intestinal function. Curr Opin Clin Nutr Metab Care. 15:474–479.
  • Letexier D, Diraison F, Beylot M. 2003. Addition of inulin to a moderately high-carbohydrate diet reduces hepatic lipogenesis and plasma triacylglycerol concentrations in humans. Am J Clin Nutr. 77:559–564.
  • Loo SW, Tan ZN, Karim AA, Hani NM, Rosma A. 2010. Fermentation of metroxylon sagu resistant starch type III by Lactobacillus sp. and Bifidobacterium bifidum. J Agric Food Chem. 58:2274–2278.
  • McIntyre A, Gibson PR, Young GP. 1993. Butyrate production from dietary fibre and protection against large bowel cancer in a rat model. Gut. 34:386–391.
  • Norvell A. 2013. Components of the immune system. In: Jaffee GCPM, editor. Cancer immunotherapy. 2nd ed. San Diego (CA): Academic Press; p. 11–24.
  • Poulsen M, Molck AM, Jacobsen BL. 2002. Different effects of short- and long-chained fructans on large intestinal physiology and carcinogen-induced aberrant crypt foci in rats. Nutr Cancer. 42:194–205.
  • Rafter J, Bennett M, Caderni G, Clune Y, Hughes R, Karlsson PC, Klinder A, O’Riordan M, O’Sullivan GC, Pool-Zobel B, et al. 2007. Dietary synbiotics reduce cancer risk factors in polypectomized and colon cancer patients. Am J Clin Nutr. 85:488–496.
  • Roy MJ, Dionne S, Marx G, Qureshi I, Sarma D, Levy E, Seidman EG. 2009. In vitro studies on the inhibition of colon cancer by butyrate and carnitine. Nutrition. 25:1193–1201.
  • Schlormann W, Hiller B, Jahns F, Zoger R, Hennemeier I, Wilhelm A, Lindhauer MG, Glei M. 2012. Chemopreventive effects of in vitro digested and fermented bread in human colon cells. Eur J Clin Nutr. 51:827–839.
  • Sun SX, Li WJ, Zhang H, Zha LY, Xue Y, Wu XB, Zou F. 2012. Requirement for store-operated calcium entry in sodium butyrate-induced apoptosis in human colon cancer cells. Biosci Rep. 32:83–90.
  • Wang B, Wang J, Zhao XH. 2017. In vitro activities of the four structurally similar flavonols weakened by the prior thermal and oxidative treatments to a human colorectal cancer line. J Food Biochem. 41:e12310.
  • Xu WL, Liu JR, Liu HK, Qi GY, Sun XR, Sun WG, Chen BQ. 2009. Inhibition of proliferation and induction of apoptosis by gamma-tocotrienol in human colon carcinoma HT-29 cells. Nutrition. 25:555–566.
  • Yin DT, Zhao XH. 2017. Impacts of exogenous strains on in vitro fermentation and anti-colon cancer activities of maize resistant starch and xylo-oligosaccharides. Starch – Stärke. 69:e1700064.
  • Zhang Q, Zhao XH, Wang ZJ. 2008. Flavones and flavonols exert cytotoxic effects on a human oesophageal adenocarcinoma cell line (OE33) by causing G2/M arrest and inducing apoptosis. Food Chem Toxicol. 46:2042–2053.
  • Zhao XH, Geng Q. 2016. Acid production and conversion of konjac glucomannan during in vitro colonic fermentation affected by exogenous microorganisms and tea polyphenols. Int J Food Sci Nutr. 67:274–282.
  • Zhao XH, Lin Y. 2009. Resistant starch prepared from high-amylose maize starch with citric acid hydrolysis and its simulated fermentation in vitro. Eur Food Res Technol. 228:1015–1021.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.